TürkiyeSGK and reimbursement
16 drugs added to SGK reimbursement list, including one for a genetic nerve disease
A statement by a ministry, institution or international organisation, or a change in regulations. It is not evidence about how well a treatment works.
With an amendment to the Sağlık Uygulama Tebliği (SUT, Health Implementation Communiqué), 16 drugs were added to the SGK (Social Security Institution) reimbursement list. Alongside cancer drugs, the list also included a drug used for a peripheral nerve disease of genetic origin. The news report did not share the active ingredient names of the drugs.
What does it mean for patients and families?
People with a genetic peripheral nerve disease can ask their neurologist: does the new coverage include their treatment?
Source
Anadolu Ajansı: SGK'nin geri ödeme listesine 5'i kanser ilacı 16 ilaç daha alındı
The source page was opened and read on October 7, 2026. Summary prepared by the Doktorclub editorial team and translated from Turkish; it has not yet been reviewed by a physician (a scientific board is being set up).
This page is translated from the Turkish original.
This page reports a development; it is not a treatment recommendation. Your doctor decides whether a treatment is right for you.